Nicorandil reduces myocardial no-reflow by protection of endothelial function via the activation of KATP channel

Clinica Chimica Acta

Volumn 374, Issue 1-2, 2006, Pages 100-105

  Zhao, Jing lin ^a   Yang, Yue jin ^a   Chen, Ji lin ^a   Kang, Lian ming ^a   Wu, Yuan ^a   Gao, Run lin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Acute myocardial infarction; Nicorandil; No reflow

Indexed keywords

GLIBENCLAMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) METHYLARGININE; NICORANDIL; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HEART INFARCTION; HEART MUSCLE NECROSIS; HEART VENTRICLE FUNCTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; STATISTICAL SIGNIFICANCE; SWINE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CORONARY CIRCULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLYBURIDE; MYOCARDIAL INFARCTION; NICORANDIL; NITRIC OXIDE SYNTHASE; ORGAN SIZE; POTASSIUM CHANNELS; SWINE; SWINE, MINIATURE; UP-REGULATION;

ANIMALIA;

EID: 33750211450     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.05.039     Document Type: Article

References (29)

1. Ito H., Okamura A., Iwakura K., et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 93 (1996) 1993-1999
2. van't Hof A.W., Liem A., de Boer M.J., et al. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 350 (1997) 615-619
3. Ito H., Maruyama A., Iwakura K., et al. Clinical implications of the 'no-reflow' phenomenon: a predictor of complications and left ventricular remodeling in perfused anterior wall myocardial infarction. Circulation 93 (1996) 223-228
4. Wu K.C., Zerhouni E.A., Judd R.M., et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97 (1998) 765-772
5. Swinburn J.M., Lahiri A., and Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J Am Coll Cardiol 38 (2001) 19-25
6. Reffelmann T., and Kloner R.A. The "no-reflow" phenomenon: basic science and clinical correlates. Heart 87 (2002) 162-168
7. Gersh B.J. Optimal management of acute myocardial infarction at the down of the next millennium. Am Heart J 138 (1999) 188-202
8. Zhao J.L., Yang Y.J., You S.J., et al. Beneficial effects of nicorandil on myocardial no-reflow state in a mini-swine model of acute myocardial infarction and reperfusion. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 17 (2005) 421-425
9. Ito H., Taniyama Y., Iwakura K., et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 33 (1999) 654-660
10. Ono H., Osanai T., Ishizaka H., et al. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J 148 (2004) E15
11. Linke A., Recchia F., Zhang X., et al. Acute and chronic endothelial dysfunction: implications for the development of heart failure. Heart Fail Rev 8 (2003) 87-97
12. Kawashima S., and Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 998-1005
13. Triggle C.R., Hollenberg M., Anderson T.J., et al. The endothelium in health and disease-a target for therapeutic intervention. J Smooth Muscle Res 39 (2003) 249-267
14. Kloner R.A., Ganote C.E., and Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54 (1974) 1496-1508
15. Qian Y.Z., Levasseur J.E., Yoshida K., et al. KATP channels in rat heart: blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide. Am J Physiol 271 (1996) H23-H28
16. Grassi B., Hogan M.C., Kelly K.M., et al. Effects of nitric oxide synthase inhibition by l-NAME on oxygen uptake kinetics in isolated canine muscle in situ. J Physiol 1; 568 Pt 3 (2005) 1021-1033
17. Nakae I., Quan L., Hashimoto K., et al. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dog. Cardiovasc Drugs Ther 8 (1994) 137-145
18. Bredt D.S., and Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci 86 (1989) 9030-9033
19. Bredt D.S., and Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci 87 (1990) 685-689
20. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
21. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 63 (1989) 18-24
22. Gavin J.B., Thomson R.W., Humphrey S.M., and Herdson P.B. Changes in vascular morphology associated with the no-reflow phenomenon in ischaemic myocardium. Virchows Arch 399 (1983) 325-332
23. Manciet L.H., Poole D.C., McDonagh P.F., Coprland J.G., and Mathieu-Costello O. Microvascular compression during myocardial ischaemia: mechanistic basis for no-reflow phenomenon. Am J Physiol 266 (1994) H1541-H1550
24. Warren J.B., Pons F., and Brady A.J.B. Nitric oxide biology: implications for cardiovascular therapeutics. Cardiovasc Res 28 (1994) 25-30
25. Matheis G., Shermn M.P., Buckberg G.D., et al. Role of l-arginine nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 262 (1992) 16-20
26. Shigeo H., Naohiko K., Teruo H., et al. Nicorandil enhances cardiac endothelial nitric oxide synthase expression via activation of adenosine triphosphate-sensitive K channel in rat. J Cardiovasc Pharmacol 38 (2001) 200-210
27. Lamping K.A., Christensen C.W., Pelc L.R., et al. Effects of nicorandil and nifedipine on protection of ischemic myocardium. J Cardiovasc Pharmacol 6 3 (1984 (May-Jun)) 536-542
28. Tsuchida A., Miura T., Miki T., et al. Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C. J Am Coll Cardiol 40 (2002) 1523-1530
29. Auchampach J.A., Cavero I., and Gross G.J. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol 20 (1992) 765-771